Robert Dreicer, MD

Dr. Dreicer on Trial Endpoints in Prostate Cancer

April 29th 2014

Robert Dreicer, MD, MS, professor of medicine at the Cleveland Clinic Lerner College of Medicine, chairman, Department of Solid Tumor Oncology, Taussig Cancer Institute, comments on current clinical trial endpoints in prostate cancer.

Dr. Dreicer on Next-Generation AR Therapies in CRPC

April 14th 2014

Robert Dreicer, MD, MS, discusses next-generation anti-androgen therapies for patients with castration-resistant prostate cancer.

Dr. Dreicer on Combining Agents With Immunotherapies

March 27th 2014

Robert Dreicer, MD, MS, discusses combining and sequencing agents with immunotherapies for the treatment of prostate cancer.

Dr. Dreicer on Prostate Cancer Drug Development Challenges

April 23rd 2013

Robert Dreicer, MD, MS, from the Cleveland Clinic in Ohio, discusses challenges facing the development of new lyase inhibitors and androgen receptor antagonists as treatments for men with prostate cancer.

Dr. Dreicer on an Alternate Sunitinib Schedule in mRCC

April 1st 2013

Robert Dreicer, MD, MS, from the Cleveland Clinic in Ohio, discusses a 2-weeks-on and 1-week-off (2/1) schedule of sunitinib for patients with metastatic renal cell carcinoma.

Dr. Dreicer on Combination Therapies in Prostate Cancer

March 20th 2013

Robert Dreicer, MD, MS, from the Taussig Cancer Institute at the Cleveland Clinic, describes potential combination therapies currently being considered as treatments for men with prostate cancer.

Dr. Dreicer on Utilizing New Prostate Cancer Therapies

May 9th 2012

Dr. Robert Dreicer, from the Cleveland Clinic, on Utilizing New Prostate Cancer Therapies

Dr. Dreicer on Sequencing MDV3100 and Abiraterone

April 18th 2012

Dr. Robert Dreicer, from the Cleveland Clinic, Discusses Sequencing MDV3100 and Abiraterone

Dr. Dreicer Discusses Using Abiraterone Acetate

April 3rd 2012

Dr. Robert Dreicer, from the Taussig Cancer Institute at the Cleveland Clinic, Discusses Using Abiraterone Acetate

Dr. Dreicer on Prostate Cancer Screening Practices

April 24th 2011

Dr. Dreicer on New Target Agents Improving Treatment

April 11th 2011

Prostate Cancer Advances From the Past 10 Years

April 6th 2011

Dr. Dreicer Talks About the State of the Healthcare System

April 5th 2011

Dr. Dreicer Remarks on Healthcare Reform

April 4th 2011

Healthcare Reform

Dr. Dreicer on Disparities in the Healthcare System

April 4th 2011

Disparities in the Healthcare System

Dr. Dreicer on the Need to Diagnose and Treat Efficiently

March 31st 2011

Dr. Dreicer on Newer Prostate Therapy Survival Benefits

March 30th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, Discusses How New Treatments Have Improved Survival

Dr. Dreicer on Prostate Cancer Combination Therapy

March 29th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, discusses the various treatments that prostate cancer patients may receive in combination.